Discover how this test is being embraced by the Life Insurance industry, from carriers to producers and policyholders alike.

In an industry often associated with death, Galleri redefines what life insurance can do by adding value not later but right now. The Galleri® test, the first-of-its-kind multi-cancer early detection test, looks for a signal shared by 50+ types of cancer with a single blood draw.

Age is the biggest risk factor for cancer. The Galleri test is recommended for adults with an elevated risk for cancer, such as those age 50 or older. Adults over age 50 are 13 times more likely to have cancer compared to people under the age of 50.

The Galleri test is a clinically-validated blood test. The Galleri test is supported by clinical studies with over 20,000 participants. Multi-cancer early detection testing may feel brand new, but it’s actually based on common and widely adopted science.

How Does Galleri Test Work?
Ron Sarra Testimonial
Kelly King Testimonial
Important Safety Information
The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. The Galleri test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. Galleri is intended to detect cancer signals and predict where in the body the cancer signal is located. Use of Galleri is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment. Results should be interpreted by a healthcare provider in the context of medical history, clinical signs and symptoms. A test result of No Cancer Signal Detected does not rule out cancer. A test result of Cancer Signal Detected requires confirmatory diagnostic evaluation by medically established procedures (e.g. imaging) to confirm cancer. If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False-positive (a cancer signal detected when cancer is not present) and false-negative (a cancer signal not detected when cancer is present) test results do occur. Rx only.
Laboratory / Test Information
The GRAIL clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists. The Galleri test was developed and its performance characteristics were determined by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration. The GRAIL clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes. Galleri is a registered trademark of GRAIL, LLC.